Newly Synthesized 3-Indolyl Furanoid Inhibits Matrix Metalloproteinase-9 Activity and Prevents Nonsteroidal Anti-inflammatory Drug-Induced Gastric Ulceration
作者:Deep Sankar Rudra、Sourav Chatterjee、Uttam Pal、Madhumita Mandal、Susri Ray Chaudhuri、Mrinmay Bhunia、Nakul Chandra Maiti、Shila Elizabeth Besra、Parasuraman Jaisankar、Snehasikta Swarnakar
DOI:10.1021/acs.jmedchem.3c00511
日期:2023.7.13
Indomethacin, a known nonsteroidal anti-inflammatory drug (NSAID) induces gastric inflammation, causing degradation of the extracellular matrix by specific matrix metalloproteinases (MMPs). We investigated the antiulcer efficacy of 3-indolyl furanoids (3g and 3c, i.e., methoxy substitution at 4- and 5-positions of the indole ring, respectively), derived from indomethacin. Interestingly, 3g protected
吲哚美辛是一种已知的非甾体类抗炎药 (NSAID),它会诱发胃部炎症,导致特定基质金属蛋白酶 (MMP) 降解细胞外基质。我们研究了源自吲哚美辛的 3-吲哚基呋喃类化合物(3g和3c,即分别在吲哚环的 4 位和 5 位上进行甲氧基取代)的抗溃疡功效。有趣的是,3g通过抑制 MMP-9 来预防体内吲哚美辛诱发的胃病。我们的工作制定了化学修饰策略,以开发更安全的非甾体抗炎药。此外,体外和计算机研究证实,3g通过与 MMP-9 的催化裂隙结合,抑制 MMP-9 活性,IC 50值为 50 μM,从而预防溃疡。药代动力学以大鼠血浆中的平均浓度-时间曲线表示,提取效率大于 70%,处理6.0 小时 ( t max ) 后的C max为 104.48 μg/mL ,半衰期和面积均在曲线分别为 7.0 h 和 1273.8 h μg/mL,表明3g的抗溃疡效力较高。